BACKGROUND: The aim of this study was to analyze the association of polymorphisms of five candidate genes with the outcome of consecutive patients admitted to a medical ICU. MATERIALS AND METHODS: The study population was prospectively recruited. Inclusion criteria were admission to the ICU and written informed consent by the patients or their relatives. A total of 533 patients were recruited. The morbidity was assessed by SAPS II Score. Outcome data of in hospital mortality and length of ICU and hospital stay were obtained. Genotyping for genetic polymorphisms (CRP 1059, IL1B -511, CTGF -477, CCR2 64VI, IL6 -174) were performed by allele-specific fluorogenic oligonucleotide probes (TaqMan analysis). RESULTS: All of the investigated polymorphisms were not associated with an altered outcome. There was no difference in morbidity and ICU or in-hospital mortality (neither in cross tabs analysis nor in Kaplan Meier or Cox regression analysis including age, gender and diagnosis as covariates) between the different genotypes. CONCLUSIONS: Genotyping of the investigated polymorphism for risk stratification of patients admitted to ICU does not seem to be appropriated.
BACKGROUND: The aim of this study was to analyze the association of polymorphisms of five candidate genes with the outcome of consecutive patients admitted to a medical ICU. MATERIALS AND METHODS: The study population was prospectively recruited. Inclusion criteria were admission to the ICU and written informed consent by the patients or their relatives. A total of 533 patients were recruited. The morbidity was assessed by SAPS II Score. Outcome data of in hospital mortality and length of ICU and hospital stay were obtained. Genotyping for genetic polymorphisms (CRP 1059, IL1B -511, CTGF -477, CCR2 64VI, IL6 -174) were performed by allele-specific fluorogenic oligonucleotide probes (TaqMan analysis). RESULTS: All of the investigated polymorphisms were not associated with an altered outcome. There was no difference in morbidity and ICU or in-hospital mortality (neither in cross tabs analysis nor in Kaplan Meier or Cox regression analysis including age, gender and diagnosis as covariates) between the different genotypes. CONCLUSIONS: Genotyping of the investigated polymorphism for risk stratification of patients admitted to ICU does not seem to be appropriated.
Authors: R C Read; N J Camp; F S di Giovine; R Borrow; E B Kaczmarski; A G Chaudhary; A J Fox; G W Duff Journal: J Infect Dis Date: 2000-10-09 Impact factor: 5.226
Authors: Francesco D'Aiuto; Juan P Casas; Tina Shah; Steve E Humphries; Aroon D Hingorani; Maurizio S Tonetti Journal: Atherosclerosis Date: 2004-12-18 Impact factor: 5.162
Authors: Amy Halverstadt; Dana A Phares; Stephen Roth; Robert E Ferrell; Andrew P Goldberg; James M Hagberg Journal: Biochim Biophys Acta Date: 2005-03-24
Authors: Reza Abdi; Tran Thi Bich Huong; Alfredo Sahagun-Ruiz; Philip M Murphy; Barry M Brenner; Edgar L Milford; David H McDermott Journal: J Am Soc Nephrol Date: 2002-03 Impact factor: 10.121
Authors: F Burzotta; L Iacoviello; A Di Castelnuovo; F Glieca; N Luciani; R Zamparelli; R Schiavello; M B Donati; A Maseri; G Possati; F Andreotti Journal: Am J Cardiol Date: 2001-11-15 Impact factor: 2.778
Authors: H Ohnishi; T Oka; S Kusachi; T Nakanishi; K Takeda; M Nakahama; M Doi; T Murakami; Y Ninomiya; M Takigawa; T Tsuji Journal: J Mol Cell Cardiol Date: 1998-11 Impact factor: 5.000